These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30878370)

  • 21. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
    Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
    Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MPO is a potential biomarker of acute graft-versus-host disease.
    Ge B; Ye H
    Biomark Med; 2013 Jun; 7(3):391-3. PubMed ID: 23734800
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation.
    Choi SI; Lee EJ; Kang DO; Lee SY; In KH; Kim HK; Park S
    Korean J Intern Med; 2016 Nov; 31(6):1181-1183. PubMed ID: 26701227
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
    Zhao Z; Leow WQ
    Transplant Proc; 2017 Sep; 49(7):1659-1662. PubMed ID: 28774674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
    Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.
    Blanchard SK; Sullivan KM; Hooten JN; Holcomb ZE; Rowe Nichols K; Selim MA; Rao CL; Hall RP; Chao NJ; Cardones AR
    Br J Dermatol; 2019 Oct; 181(4):869-871. PubMed ID: 31017659
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.
    Hebenstreit K; Iacobelli S; Leiblein S; Eisfeld AK; Pfrepper C; Heyn S; Vucinic V; Franke GN; Krahl R; Fricke S; Becker C; Pönisch W; Behre G; Niederwieser D; Lange T
    Leuk Lymphoma; 2014 Jun; 55(6):1274-80. PubMed ID: 23964650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Dong A; Gao M; Wang Y; Gao L; Zuo C
    Clin Nucl Med; 2016 Sep; 41(9):e414-6. PubMed ID: 26909714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation.
    Goyal PKK; Xu S; Choi J
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-host disease: case report and review of literature.
    Jing X; Halat S; Meleg-Smith S
    J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow transplantation for sickle cell disease.
    Walters MC; Patience M; Leisenring W; Eckman JR; Scott JP; Mentzer WC; Davies SC; Ohene-Frempong K; Bernaudin F; Matthews DC; Storb R; Sullivan KM
    N Engl J Med; 1996 Aug; 335(6):369-76. PubMed ID: 8663884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
    [No Abstract]   [Full Text] [Related]  

  • 38. Hashimoto encephalopathy as manifestation of central nervous system chronic graft-versus-host disease after hematopoietic stem cell transplantation.
    Vicent MG; Cantarín V; Guerrero C; Molina B; Nieto M; López P; Iglesias MI; Díaz MA
    Pediatr Blood Cancer; 2019 Dec; 66(12):e28008. PubMed ID: 31535441
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
    Pechey V; Parratt J; Vo L; Stevenson W
    Int J Hematol; 2015 Feb; 101(2):203-6. PubMed ID: 25416235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients.
    Tumino M; Serafin V; Accordi B; Spadini S; Forest C; Cortese G; Lissandron V; Marzollo A; Basso G; Messina C
    Br J Haematol; 2015 Jan; 168(1):142-5. PubMed ID: 25098229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.